Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Mestre
Clinical trial register · Italy

Clinical Trials in Mestre, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Milan 2843 Bologna 1305 Roma 1274 Naples 984 Rome 967
Narrow the registerReset
Recruitment status
Phase
Site location
Milan2843 Bologna1305 Roma1274 Naples984 Rome967
All 489 locations
Target enrolment
to

Trials with a site in Mestre

14 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Acesion Pharma
Phase 2
200
Bologna, Cona, Mestre, Milan, Modena
2025-10-22
By invitation
Rede Optimus Hospitalar SA
Not applicable
620
Palermo, Pisa, Catania, Mestre, Roma, Siena, Trieste
2025-08-08
Active, closed
FARAPULSE Workflow Assessment Registry
NCT06656884Atrial Fibrillation (AF)
Boston Scientific Corporation
Observational
524
Ferrara, Mestre, Monza, Rivoli, Vicenza
2025-05-06
Recruiting
Focused Ultrasound Unilateral Pallidotomy for Medication-Refractory Limb Dystonia
NCT07168850Limb Dystonia, Idiopathic Dystonia, Medication-refractory Dystonia, Dystonia, Focal
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Not applicable
34
Mestre, Messina, Milan, Palermo
2025-01-27
Recruiting
TRAns-Femoral Access Intravascular Lithotripsy Comparison With PTA in TAVI
NCT05873842Trans-femoral TAVI With Calcified Ilio-femoral Arteries
Rede Optimus Hospitalar SA
Observational
50
Ancona, Mestre, Treviso, Verona, Vicenza
2024-07-22
Recruiting
AstraZeneca
Phase 3
5,250
Ancona, Florence, Genoa, Mestre, Milan, Naples, Pavia, Perugia
2024-02-21
Recruiting
Istituto Oncologico Veneto IRCCS
Observational
150
Brixen, Abano Terme, Dolo, Bassano del Grappa, Mestre, Padova, Trieste, Udine
2023-01-23
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 3
162
Meldola, Alessandria, Bari, Catania, Chieti, Ferrara, Genova, Mestre
2021-12-14
Recruiting
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
NCT04867915Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, MBL-CLL - Monoclonal B-Cell Lymphocytosis Chronic Lymphocytic Leukaemia-Type
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
12,500
Alessandria, Brescia, Brindisi, Candiolo, Florence, Messina, Mestre, Milan
2021-10-13
Active, closed
Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL
NCT04722848Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), ALL, Adult, Philadelphia-Positive ALL
Gruppo Italiano Malattie EMatologiche dell'Adulto
Phase 3
236
Ascoli Piceno, Bari, Bergamo, Bolzano, Brescia, Mestre, Modena, Pagani
2021-09-08
Active, closed
German CLL Study Group
Phase 3
897
Catania, Ferrara, Mestre, Milan, Perugia, Roma, Torino
2021-03-01
Active, closed
A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic Leukemia
NCT03589326Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)
Takeda
Phase 3
245
Meldola, Genoa, Monza, Reggio Emilia, Mestre, Bologna, Lecce, Milan
2018-10-04
Recruiting
Boston Scientific Corporation
Observational
300
Ferrara, Mestre, Rome, Udine
2016-03-07
Recruiting
Boston Scientific Corporation
Observational
1,500
Arcugnano, Ferrara, Mestre, Milan, Pavia, Rome, Udine
2014-03-04
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/mestre

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Mestre.

How many clinical trials are recruiting in Mestre?

9 of the 14 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 4 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Mestre), 14 studies
PhaseStudiesRecruitingShare
Observational6542.9%
Phase 35235.7%
Not applicable2114.3%
Phase 2117.1%

Most active sponsors

Lead sponsors with the most studies (Mestre)
Lead sponsorStudiesRecruiting
Boston Scientific Corporation32
Gruppo Italiano Malattie EMatologiche dell'Adulto21
Rede Optimus Hospitalar SA21
Acesion Pharma11
AstraZeneca11
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta11
German CLL Study Group10
Gruppo Oncologico Italiano di Ricerca Clinica11
Istituto Oncologico Veneto IRCCS11
Takeda10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.